“5am-ventures” Archives

in
Entry Author Date Location
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments 08/15/11 Boston
Pulmatrix Secures $14,000,000 Series B Funding 08/15/11 Boston
DVS Sciences Secures $14,600,000 Series A Funding Round 07/14/11 San Francisco
VBI Progressing with Vaccines That Don’t Require Refrigeration 03/24/11 Boston
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
DARPA Backs Pulmatrix’s Lung Treatment, Adimab Scores More Pharma Partners, Semprus Secures $18M, & More Boston-Area Life Sciences News 12/17/10 Boston
BG Medicine Eyes $70M IPO, Nano-Terra Picks Up $17.2M, Rive Technology Raises $25M, & More Boston-Area Deals News 12/15/10 Boston
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats 12/14/10 Boston
Semprus Scores $18M More to Help Improve Medical Devices 12/13/10 Boston
Anaphore Snags $110M Deal With Mitsubishi Tanabe to Make Drugs for Immune Disorders 12/13/10 San Diego
Semprus BioSciences Lands $18,000,000 Series B Round 12/13/10 Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial 12/01/10 San Francisco
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks 10/26/10 San Diego
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News 10/22/10 San Francisco
Pearl Therapeutics Gets $69M 10/19/10 San Francisco
Pearl Therapeutics Receives $69,000,000 Series C Financing Round 10/19/10 San Francisco
Synosia Raises $30M, Strikes Deal With UCB Worth Up to $725M for Parkinson’s Drugs 10/12/10 San Francisco
Relypsa Snags $70M Venture Round to Get Rid of Excess Potassium in Blood 09/13/10 San Francisco
Relypsa Obtains $70,000,000 Series B Funding 09/13/10 San Francisco
Michigan’s Renaissance “Fund of Funds” Closes at Nearly $50M, Ready to Make Connections Between VCs and Entrepreneurs 09/07/10 Detroit Ann Arbor
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
Ingenuity Systems Adds $15.3M 07/02/10 San Francisco
Incline Therapeutics Secures $43,000,000 Series A Round 06/22/10 San Francisco
Igenica Lands $24,000,000 Series B Financing Round 06/11/10 San Francisco
Viveve Receives $4,000,000 New Funding 04/29/10 San Francisco
Concur Goes Convertible, Frazier and Arch Back Achaogen, Lucid Commerce Gets Cash, & More Seattle-Area Deals News 04/14/10 Seattle
Frazier, Arch Join $56M Antibiotic Deal 04/07/10 Seattle
Achaogen Obtains $56,000,000 Series C Funding Round 04/07/10 San Francisco
Pearl Therapeutics Garners $15,000,000 Series C Round 02/01/10 San Francisco
5AM Gathers $200M Fund, Advanced Cell Technology Advances with $2.8 Million, Gloucester Picked up for $640M, & More Boston-Area Deals News 12/11/09 Boston
Page 3 of 5 « previous page · next page »